- Home
- RLAY vs GSBC Comparison
RLAY vs GSBC Comparison
Compare RLAY & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- GSBC
- Stock Information
- Founded
- RLAY 2015
- GSBC 1923
- Country
- RLAY United States
- GSBC United States
- Employees
- RLAY N/A
- GSBC N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- GSBC Major Banks
- Sector
- RLAY Health Care
- GSBC Finance
- Exchange
- RLAY Nasdaq
- GSBC Nasdaq
- Market Cap
- RLAY 619.0M
- GSBC 676.3M
- IPO Year
- RLAY 2020
- GSBC N/A
- Fundamental
- Price
- RLAY $4.12
- GSBC $63.49
- Analyst Decision
- RLAY Strong Buy
- GSBC Hold
- Analyst Count
- RLAY 13
- GSBC 2
- Target Price
- RLAY $18.00
- GSBC $60.50
- AVG Volume (30 Days)
- RLAY 1.5M
- GSBC 34.5K
- Earning Date
- RLAY 11-05-2025
- GSBC 10-15-2025
- Dividend Yield
- RLAY N/A
- GSBC 2.52%
- EPS Growth
- RLAY N/A
- GSBC 17.24
- EPS
- RLAY N/A
- GSBC 5.86
- Revenue
- RLAY $8,355,000.00
- GSBC $224,299,000.00
- Revenue This Year
- RLAY $31.55
- GSBC N/A
- Revenue Next Year
- RLAY N/A
- GSBC N/A
- P/E Ratio
- RLAY N/A
- GSBC $10.84
- Revenue Growth
- RLAY N/A
- GSBC 4.82
- 52 Week Low
- RLAY $1.78
- GSBC $47.58
- 52 Week High
- RLAY $10.72
- GSBC $68.02
- Technical
- Relative Strength Index (RSI)
- RLAY 65.83
- GSBC 63.51
- Support Level
- RLAY $3.52
- GSBC $62.35
- Resistance Level
- RLAY $4.26
- GSBC $63.78
- Average True Range (ATR)
- RLAY 0.22
- GSBC 1.06
- MACD
- RLAY 0.07
- GSBC 0.25
- Stochastic Oscillator
- RLAY 85.26
- GSBC 70.52
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.